ORAMED PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
ORAMED PHARMACEUTICALS INC. (ORMP) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $123.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2022-11-10
- 2022-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $123.00K.
- 2022-06-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $124.00K.
- 2022-03-31: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $137.00K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2022-09-30 | $123.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $124.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $137.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |